No Arabic abstract
Purpose: Currently, calculations of proton range in proton therapy patients are based on a conversion of CT Hounsfield Units of patient tissues into proton relative stopping power. Uncertainties in this conversion necessitate larger proximal and distal planned target volume margins. Proton CT can potentially reduce these uncertainties by directly measuring proton stopping power. We aim to demonstrate proton CT imaging with complex porcine samples, to analyze in detail three-dimensional regions of interest, and to compare proton stopping powers directly measured by proton CT to those determined from x-ray CT scans. Methods: We have used a prototype proton imaging system with single proton tracking to acquire proton radiography and proton CT images of a sample of porcine pectoral girdle and ribs, and a pigs head. We also acquired close in time x-ray CT scans of the same samples, and compared proton stopping power measurements from the two modalities. In the case of the pigs head, we obtained x-ray CT scans from two different scanners, and compared results from high-dose and low-dose settings. Results: Comparing our reconstructed proton CT images with images derived from x-ray CT scans, we find agreement within 1% to 2% for soft tissues, and discrepancies of up to 6% for compact bone. We also observed large discrepancies, up to 40%, for cavitated regions with mixed content of air, soft tissue, and bone, such as sinus cavities or tympanic bullae. Conclusions: Our images and findings from a clinically realistic proton CT scanner demonstrate the potential for proton CT to be used for low-dose treatment planning with reduced margins.
Purpose: Dual-energy CT (DECT) has been used to derive relative stopping power (RSP) map by obtaining the energy dependence of photon interactions. The DECT-derived RSP maps could potentially be compromised by image noise levels and the severity of artifacts when using physics-based mapping techniques, which would affect subsequent clinical applications. This work presents a noise-robust learning-based method to predict RSP maps from DECT for proton radiation therapy. Methods: The proposed method uses a residual attention cycle-consistent generative adversarial (CycleGAN) network. CycleGAN were used to let the DECT-to-RSP mapping be close to a one-to-one mapping by introducing an inverse RSP-to-DECT mapping. We retrospectively investigated 20 head-and-neck cancer patients with DECT scans in proton radiation therapy simulation. Ground truth RSP values were assigned by calculation based on chemical compositions, and acted as learning targets in the training process for DECT datasets, and were evaluated against results from the proposed method using a leave-one-out cross-validation strategy. Results: The predicted RSP maps showed an average normalized mean square error (NMSE) of 2.83% across the whole body volume, and average mean error (ME) less than 3% in all volumes of interest (VOIs). With additional simulated noise added in DECT datasets, the proposed method still maintained a comparable performance, while the physics-based stoichiometric method suffered degraded inaccuracy from increased noise level. The average differences in DVH metrics for clinical target volumes (CTVs) were less than 0.2 Gy for D95% and Dmax with no statistical significance. Conclusion: These results strongly indicate the high accuracy of RSP maps predicted by our machine-learning-based method and show its potential feasibility for proton treatment planning and dose calculation.
Purpose: Dual-energy CT (DECT) has been shown to derive stopping power ratio (SPR) map with higher accuracy than conventional single energy CT (SECT) by obtaining the energy dependence of photon interactions. However, DECT is not as widely implemented as SECT in proton radiation therapy simulation. This work presents a learning-based method to synthetize DECT images from SECT for proton radiation therapy. Methods: The proposed method uses a residual attention generative adversarial network. Residual blocks with attention gates were used to force the model focus on the difference between DECT maps and SECT images. To evaluate the accuracy of the method, we retrospectively investigated 20 head-and-neck cancer patients with both DECT and SECT scans available. The high and low energy CT images acquired from DECT acted as learning targets in the training process for SECT datasets and were evaluated against results from the proposed method using a leave-one-out cross-validation strategy. To evaluate our method in the context of a practical application, we generated SPR maps from sDECT using physics-based dual-energy stoichiometric method and compared the maps to those generated from DECT. Results: The synthesized DECT images showed an average mean absolute error around 30 Hounsfield Unit (HU) across the whole-body volume. The corresponding SPR maps generated from synthetic DECT showed an average normalized mean square error of about 1% with reduced noise level and artifacts than those from original DECT. Conclusions: The accuracy of the synthesized DECT image by our machine-learning-based method was evaluated on head and neck patient, and potential feasibility for proton treatment planning and dose calculation was shown by generating SPR map using the synthesized DECT.
Radiation therapy with protons as of today utilizes information from x-ray CT in order to estimate the proton stopping power of the traversed tissue in a patient. The conversion from x-ray attenuation to proton stopping power in tissue introduces range uncertainties of the order of 2-3% of the range, uncertainties that are contributing to an increase of the necessary planning margins added to the target volume in a patient. Imaging methods and modalities, such as Dual Energy CT and proton CT, have come into consideration in the pursuit of obtaining an as good as possible estimate of the proton stopping power. In this study, a Digital Tracking Calorimeter is benchmarked for proof-of-concept for proton CT purposes. The Digital Tracking Calorimeteris applied for reconstruction of the tracks and energies of individual high energy protons. The presented prototype forms the basis for a proton CT system using a single technology for tracking and calorimetry. This advantage simplifies the setup and reduces the cost of a proton CT system assembly, and it is a unique feature of the Digital Tracking Calorimeter. Data from the AGORFIRM beamline at KVI-CART in Groningen in the Netherlands and Monte Carlo simulation results are used to in order to develop a tracking algorithm for the estimation of the residual ranges of a high number of concurrent proton tracks. The range of the individual protons can at present be estimated with a resolution of 4%. The readout system for this prototype is able to handle an effective proton frequency of 1 MHz by using 500 concurrent proton tracks in each readout frame, which is at the high end range of present similar prototypes. A future further optimized prototype will enable a high-speed and more accurate determination of the ranges of individual protons in a therapeutic beam.
Proton beam therapy can potentially offer improved treatment for cancers of the head and neck and in paediatric patients. There has been a sharp uptake of proton beam therapy in recent years as improved delivery techniques and patient benefits are observed. However, treatments are currently planned using conventional x-ray CT images due to the absence of devices able to perform high quality proton computed tomography (pCT) under realistic clinical conditions. A new plastic-scintillator-based range telescope concept, named ASTRA, is proposed here as the energy tagging detector of a pCT system. Simulations conducted using Geant4 yield an expected energy resolution of 0.7% and have demonstrated the ability of ASTRA to track multiple protons simultaneously. If calorimetric information is used the energy resolution could be further improved to about 0.5%. Assuming clinical beam parameters the system is expected to be able to efficiently reconstruct at least, 10$^8$ protons/s. The performance of ASTRA has been tested by imaging phantoms to evaluate the image contrast and relative stopping power reconstruction.
The design, construction, and preliminary testing of a second generation proton CT scanner is presented. All current treatment planning systems at proton therapy centers use X-ray CT as the primary imaging modality for treatment planning to calculate doses to tumor and healthy tissues. One of the limitations of X-ray CT is in the conversion of X-ray attenuation coefficients to relative (proton) stopping powers, or RSP. This results in more proton range uncertainty, larger target volumes and therefore, more dose to healthy tissues. To help improve this, we present a novel scanner capable of high dose rates, up to 2~MHz, and large area coverage, 20~x~24~cm$^2$, for imaging an adult head phantom and reconstructing more accurate RSP values.